Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-08-03

Clinical Trial Update: A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF [Phase 1]

View source ↗

Summary

Phase 1 study investigating downregulation of epidermal growth factor receptors in the skin after topical exposure to epidermal growth factor in patients with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical epidermal growth factor (EGF) (epidermal growth factor)

Snippet

Sponsor: Ennar Pharmaceuticals AF | Conditions: Plaque Psoriasis | Phase 1 | Status: UNKNOWN